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ABBREVIATIONS
AACPDM American Academy for Cerebral
Palsy and Developmental
Medicine
HABIT-ILE Hand–arm bimanual intensive
therapy including lower
extremities
ICF International Classification of
Functioning, Disability and
Health
ITB Intrathecal baclofen
MACS Manual Ability Classification
System
RCT Randomized controlled trial
SDR Selective dorsal rhizotomy
AIM To systematically review the efficacy of interventions on upper limb function in children
0 to 19 years of age with bilateral cerebral palsy on the basis of outcome measures of upper
limb function and measures of activities and/or participation according to the International
Classification of Functioning, Disability and Health.
METHOD Cochrane, PubMed, Embase, CINAHL, and Web of Science were searched from
inception to September 2017. Methodological quality and strength of evidence were analysed
by two independent raters using Sackett’s level of evidence and the American Academy for
Cerebral Palsy and Developmental Medicine (AACPDM) guidelines.
RESULTS Fifteen studies with a large variety of interventions and heterogeneity in outcome
measures met the inclusion criteria. Twelve studies provided level IV evidence according to
AACPDM guidelines. For three small randomized controlled trials the level of evidence was II.
Only one of these trials showed strong methodological quality: a study on hand–arm
bimanual intensive therapy including lower extremities.
INTERPRETATION We identified a large variety of interventions, heterogeneity in outcome
measures, and generally weak to moderate methodological quality for most studies. We
recommend further research specifically aimed at bimanual-intensive, goal-directed, and task-
specific training programmes for the upper limb in children with bilateral cerebral palsy,
using either high-quality (multicentre) trials or well-designed single-case trials.
Cerebral palsy (CP) is a disorder with an estimated preva-
lence of 2 in 1000 live births1 and is divided into three
subtypes: spastic, dyskinetic, and ataxic.2 The spastic type
of CP is further categorized into unilateral or bilateral dis-
tribution; the dyskinetic and ataxic types are commonly
viewed as distributed bilaterally.3,4 In the case of a mixed
form of CP, the child is classified according to the domi-
nant clinical feature. In spastic CP, some dystonic features
are often present, especially when the upper extremities are
involved.4 The term bilateral (spastic) CP as recommended
by the Surveillance of Cerebral Palsy in Europe2 has been
widely accepted as an alternative to the frequently used
terms diplegia, tetraplegia, or quadriplegia. It is the most
common subtype, as it constitutes about 55% of all
patients with CP.2
More than 60% of children with bilateral CP have
impaired hand function.5 Manual ability among these chil-
dren is typically classified within all levels of the Manual
Ability Classification System (MACS),6 including the more
severe MACS levels IV and V,5,7 whereas children with
unilateral CP are usually classified within MACS levels I to
III. In children with CP, limited ability to manipulate
objects with the hands is reported as one of the strongest
predictors of limitations in everyday activities and partici-
pation restrictions.7 Therefore, improving manual abilities
is one of the most important treatment goals.
Treatments targeting upper limb function in children
with CP aim to improve functional abilities, promote func-
tional independence, and/or reduce disabling muscle tone.
Frequently reported treatments are constraint-induced
movement therapy, bimanual training, virtual reality and
computer-based training, or combinations of these treat-
ments with intramuscular chemodenervation by botulinum
neurotoxin A (BoNT-A).8,9 However, current effectiveness
studies for upper limb function predominantly focus on
children with unilateral spastic CP. For spasticity manage-
ment in all types including bilateral CP, intramuscular
BoNT-A, oral diazepam, or selective dorsal rhizotomy
(SDR) have proved to be effective.10 However, the focus of
these interventions is usually on the effects on the lower
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limbs rather than the upper limbs. Thus, knowledge about
interventions to improve upper limb function in children
with bilateral CP is limited.7
So far, results on the effectiveness of interventions on
upper limb function in children with bilateral CP have not
been systematically summarized. One older systematic
review11 of all types of intervention for upper limb spastic-
ity focused on children with unilateral as well as bilateral
CP. In this review, no evidence for the effectiveness of
intrathecal baclofen (ITB) or SDR could be established.
There were no signs of improved functional skills of the
upper limbs. Several other authors reviewed the efficacy of
upper limb treatment for unilateral spastic CP.9,12,13 As
none of these reviews specifically focused on children with
bilateral CP, or they restricted their focus to only one
treatment modality, a comprehensive overview of the effi-
cacy of various interventions on upper limb function in
these children is not available.
The aim of this systematic review was to provide an
overview of interventions on upper limb function in chil-
dren 0 to 19 years of age with bilateral CP and to syn-
thesize research data on the effectiveness of these
interventions. The main clinical question was ‘what is
known about the efficacy of interventions on upper limb
function in children with bilateral CP?’. To answer this,
we reviewed the literature published from inception to
September 2017, and systematically evaluated the efficacy
of interventions on upper limb function in children with
bilateral CP. In addition, we assessed the methodological
quality of the studies using the guidelines of the Ameri-
can Academy for Cerebral Palsy and Developmental
Medicine (AACPDM).14 Outcome measures were classi-
fied according to the components of the International
Classification of Functioning, Disability and Health
(ICF).15
METHOD
Search strategy
Relevant articles were identified by searching the Cochrane
Library (1946–2017), CINAHL (1982–2017), Embase
(1974–2017), PubMed (1946–2017), and Web of Science
(1945–2017). The search of published studies was per-
formed on 27th July 2016 and updated on 15th September
2017. Reference lists of selected articles were also reviewed
by two reviewers (JEV and VFPP) for studies not retrieved
by the electronic search.
Exploded Medical Subject Heading (MeSH) terms and
key words used in PubMed were as follows: (1) cerebral
palsy AND (2) quadriplegi*OR diplegi*OR bilatera*AND
(upper extremit*OR upper limb*) AND (function*OR per-
form*) AND Treatment*OR Therap*OR Surger*OR
Splint OR Botulinum toxin*.
A language restriction to publications in English,
French, and German was included owing to a lack of
translation services. MeSH and a thesaurus were used to
customize the search terms for each database. The search
strategy was adapted by an experienced librarian to make it
applicable to other databases. The full search strategy is
given in Appendix S1 (online supporting information).
Selection criteria
Inclusion criteria
To be included, studies had to meet the following four cri-
teria. (1) The study population consisted of at least 10 chil-
dren or adolescents diagnosed with bilateral CP in the age
range 0 to 19 years. Studies of mixed age groups were
included if data of participants aged 0 to 19 years were
reported separately. (2) The study investigated the effect of
a surgical, pharmacological (e.g. BoNT-A), or non-
pharmacological treatment, whether used independently or
in combination, on upper limb function. (3) Data collec-
tion was prospective in nature (e.g. pre/posttest designs,
randomized controlled trials [RCTs]). (4) Outcome mea-
sures reflected upper limb function as well as activities
and/or participation according to the ICF.
Studies were excluded if (1) the data for upper limb
function were not separately described in the case of mixed
data outcomes for the upper and lower extremities or (2)
the article was a review, survey, anecdote, letter, or com-
ment, or was published in a non-peer-reviewed journal (in
line with AACPDM policy and procedures).
Procedures for inclusion, quality assessment, and data
extraction
Eligibility for inclusion, based on title and abstract, was
assessed independently by two reviewers (JEV and VFPP).
Abstracts meeting inclusion criteria or requiring more
information from the full text to verify inclusion were
retained. The full text was read to determine its suitability
when in doubt. Articles were included when agreement
between reviewers was achieved. The full texts of articles
that met the inclusion criteria were retrieved and examined
in more detail to: (1) assess methodological quality; and (2)
synthesize research data on the effectiveness of the inter-
ventions.
Methodological assessment
Level of evidence and methodological quality
First, the level of quantitative evidence of each study was
assessed according to Sackett’s methodology.16 Second, all
included studies were scored on their methodological
rigour using the criteria of the AACPDM Treatment
Outcome Committee.14 According to the AACPDM
guidelines, level IV and V studies would not have to be
assessed on their methodological quality. Preliminary
What this paper adds
• There is a large variety of interventions on upper limb function in children
with bilateral cerebral palsy.
• Heterogeneity of outcome measures and interventions impeded firm conclu-
sions about intervention efficacy.
• Most studies had low-level evidence and weak to moderate methodological
quality.
• The strongest evidence from a small randomized controlled trial was for
hand–arm bimanual intensive therapy including lower extremities.
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screening showed that most studies had less rigorous
research designs. Nevertheless, we decided to include and
review all studies as a means of informing future studies.
The grading of the studies and scoring on their method-
ological rigor were conducted independently by two raters
(JEV and VFPP). AACPDM methodology levels were
operationalized (Table SI, online supporting information)
and scored by two reviewers independently (JEV and
VFPP). In the case of disagreement or any discrepancies
in scores, details were discussed until consensus was
reached. One reviewer (VFPP) extracted the data and
entered data items into a data extraction summary form.
Data were extracted according to the participants, inter-
ventions, comparators, outcomes, study design (PICOS)
approach, as emphasized in the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses (PRISMA)
statement17 for reporting systematic reviews, and com-
prised the research design (i.e. Sackett’s levels of evi-
dence), eligibility criteria, diagnosis including motor type,
patient characteristics, number of participants, interven-
tion, and comparison group details.
Data analysis
Studies were categorized by type of intervention and all
outcomes were specified on the basis of consensus by two
reviewers (PBMA and VFPP) according to the ICF frame-
work.15 A summarizing table including p-values was con-
structed according to the AACPDM14 outcomes of interest
for two ICF categories: ‘body function and structures’ and
‘activities and participation’. Considering the heterogeneity
of outcome measures in the included studies, we decided
to categorize the different outcome measures within the
ICF domains on the basis of consensus of three authors
(CHMVDE, PBMA, and VFPP). From this table, a more
concise one with an overview of seven relevant outcome
domains was constructed comprising mobility of joint
functions, muscle power, muscle tone, movement functions
(ICF domain ‘body functions and structures’) and hand
and arm use, fine hand use, and self-care (ICF domain ‘ac-
tivities and participation’).
For each outcome domain, the reported effect was
scored as positive (‘+’) or negative (‘’) when results were
statistically significant; as no effect (‘0’) when results were
not statistically significant; and as not applicable (‘NA’) if
not measured. Both within-group and between-group
results with a p-value less than 0.05 were considered statis-
tically significant. Standardized mean differences (Cohen’s
d) were calculated using statistical package STATA/IC
13.1 (StataCorp LLC, College Station, TX, USA) for sig-
nificant between-group differences where possible. Several
decision rules were defined to score the effectiveness. First,
when multiple outcome measures and/or subscales were
used to assess the same outcome domain within a study,
then more than 50% of the outcome measures needed to
score ‘+’ to report an effect as positive. Second, when total
scores were provided, those scores were preferred to the
results of subscale scores.
RESULTS
Study selection
The search strategy yielded 493 studies; 63 met the eligi-
bility criteria after the first selection based on title and
abstract. A flow chart of the selection process is shown in
Figure S1 (online supporting information). The full articles
of these 63 studies were reviewed and 46 studies were sub-
sequently excluded for the following reasons: diagnosis,18–25
age,26–29 sample size,30–49 design,50–53 intervention,54–57 and
outcome measure.58–63 Of the remaining 17 studies, two
articles reported data on mixed study samples consisting of
participants with quadriplegia, diplegia, traumatic brain
injury, and spinal cord injury (among others)64 or partici-
pants with quadriplegia, diplegia, hemiplegia, and ataxia.65
As the results for bilateral CP were not separately reported,
the authors were approached and asked whether they
could supply more specific data. Because these data could
not be retrieved, the two studies64,65 were excluded. There-
fore, this review included 15 studies66–80 investigating the
efficacy of interventions on upper limb function in children
with bilateral CP.
Study characteristics
Five of the 15 included studies were cohort studies without
a control group, six were case series, one was a case–con-
trol study, and three were small RCTs66,67,80 (Table SII,
online supporting information). Three small RCTs pro-
vided level II evidence and 12 studies level IV evidence.
Thus, most of the studies provided low-level evidence
according to Sackett’s criteria. Table I depicts the method-
ological quality of all included studies. The three RCTs
showed strong,67 moderate,80 and weak66 methodological
quality whereas one study75 with level IV evidence was
rated as strong. Of all AACPDM criteria, ‘statistical evalu-
ation’ and ‘assessor blinding’ were least met. The quality
was weak for nine studies, moderate for four, and strong
for two (Table I).
In two RCTs the control group received no interven-
tion; in one study the control group received usual care
consisting of physical therapy. The mean age of partici-
pants in the included studies ranged from 4 years
6 months to 12 years 6 months and the total number was
288, varying from 10 to 40 per study. The proportion of
females ranged from 10% (one out of 10) to 67% (eight
out of 12) in 14 studies; one study included only males.76
Motor type of CP was described in different ways. Eight
studies had homogenous populations and consisted only of
children with spastic diplegia; four studies had heteroge-
neous populations and consisted of a mixed population
with both quadriplegia and diplegia. Two studies lacked
information about the distribution of children with diplegia
and quadriplegia in their study population.71,73 One study
exclusively presented children with spastic quadriplegia.80
Within the studies with mixed populations, the proportion
of children with diplegia ranged from 10.5% (two out of
21) to 69% (20 out of 29). As for the manual abilities,
MACS6 levels were documented in four studies. One
Review 901
study73 reported that the distinction between children with
diplegia and quadriplegia was made on the basis of observ-
able functional deficits of the upper extremities. Gross
motor function was classified by the Gross Motor Function
Classification Scale (GMFCS)81 in eight studies; in three
studies, there was no further classification of motor level;
four studies described merely the level of ambulation.
Study samples were recruited from a large variety of set-
tings ranging from a children’s hospital and a regional
medical centre to rehabilitation institutes. In three studies
the setting was not documented. In 10 studies exclusion
criteria were reported,66,67,72,74–80 including different types
of comorbidity: severe hearing loss, visual impairment, epi-
lepsy, autism, history of BoNT-A or phenol injections,
neurosurgery, or ophthalmic surgery.
Ten different interventions were identified: (1) BoNT-A
injections with or without occupational therapy; (2) SDR
and occupational therapy/physical therapy; (3) ITB and
physical therapy; (4) hand–arm bimanual intensive therapy
including lower extremities (HABIT-ILE) training; (5)
Armeo Spring device training combined with occupational
therapy; (6) transcranial magnetic stimulation; (7) hyper-
baric oxygen therapy; (8) Wii/virtual reality training; (9)
sitting/standing positioning; and (10) hippotherapy. In
seven studies participants received a single treatment
modality; in the other eight studies treatment was com-
bined with occupational therapy or physical therapy
(Table SII).
Efficacy of interventions across outcome domains of the
ICF
The effectiveness of 15 studies was assessed and summa-
rized across the relevant ICF domains according to the
AACPDM guidelines (Table SIII, online supporting infor-
mation). An overview of the efficacy of the interventions
sorted by seven relevant outcome domains is shown in
Table II. Outcome measures that reflected the ICF domain
‘body functions and structures’ included range of move-
ment, muscle strength, muscle tone, and coordination. The
ICF domain of ‘activity and participation’ was reflected in
fine hand use, arm and hand use, and self-care. Contextual
factors were reported by three studies, including subjective
parent reported symptoms,80 a caregivers report on
achieved goals,70 and caregiver’s health-related quality of
life.74 However, measures of these studies were minimally
related to upper limb function and therefore are not pre-
sented.
The effectiveness of three interventions (BoNT-A with
or without occupational therapy, SDR and occupational
therapy/physical therapy, and Wii virtual reality training)
was described by more than one study. Six studies on the
effectiveness of BoNT-A with or without occupational
therapy72,74 and SDR and occupational therapy/physical
therapy68,69,71,73 showed level IV evidence, and two studies
on Wii virtual reality training66,77 provided level II and IV
evidence respectively. Significant beneficial effects on dif-
ferent outcome measures in six out of seven domains were
reported by two studies on the effectiveness of BoNT-A
with or without occupational therapy.72,74 In three out of
four studies that examined the effectiveness of SDR and
occupational therapy/physical therapy,68,69,71,73 a signifi-
cant improvement on the domain of self-care was reported;
however, in the remaining domains, outcome domain find-
ings were non-significant or inconsistent. In addition, one
study on SDR and occupational therapy/physical therapy68
reported a significant effect on grasp strength and fine
motor coordination, represented in two domains. Two
studies, a case–control study77 and one small RCT,66
examined the effectiveness of Wii virtual reality training.
The small RCT (level II evidence) reported significant
improvements in three domains: movement functions (i.e.
upper limb coordination), hand and arm use, and fine hand
use.
The effectiveness of seven other interventions was
described by a single study. Five of these studies (two
cohort studies and three case series) showed level IV evi-
dence, and assessed the effectiveness of the following inter-
ventions: ITB and physical therapy,70 Armeo Spring device
training combined with occupational therapy,79 hyperbaric
oxygen,75 positioning,76 and hippotherapy.78 Lewin et al.73
documented the effect of ITB and physical therapy in a
mixed population of patients with spastic diplegia and
quadriplegia. Because data of upper limb mobility patterns
and muscle tone were not presented for the whole group
but only for the group of patients who made gains, it was
Table I: Conduct of study
Study Qualitya 1 2 3 4 5 6 7
BoNT-A only/BoNT-A and OT
Lee et al.72 W 3/7 N Y Y N N Y N
Lin et al.74 M 4/7 Y Y Y N N Y N
SDR and OT/PT
Buckon et al.68 W 2/7 N N Y N N N Y
Buckon et al.69 M 4/7 N Y Y N N Y Y
Dudgeon et al.71 W 3/7 N Y Y N N Y N
Lewin et al.73 W 2/7 N N N N N Y Y
Intrathecal baclofen and PT
Campbell et al.70 W 3/7 N Y Y N N Y N
HABIT-ILE-training
Bleyenheuft et al.67 S 6/7 Y Y Y N Y Y Y
Armeo Spring and OT
Turconi et al.79 M 5/7 Y Y Y N N Y Y
Transcranial magnetic stimulation
Valle et al.80 M 5/7 Y Y Y Y N N Y
Wii/virtual reality training
Alsaif and Alsenany66 W 2/7 N N Y N N N Y
Shin et al.77 W 0/7 N N N N N N N
Positioning
Noronha et al.76 W 2/7 N Y Y N N N N
Hippotherapy
Shurtleff et al.78 W 3/7 Y N N N N Y Y
Hyperbaric oxygen therapy
Montgomery et al.75 S 6/7 Y Y Y Y N Y Y
Methodology assessment according to the American Academy for
Cerebral Palsy and Developmental Medicine. aQuality of the con-
duct of the study. BoNT-A, botulinum neurotoxin A; HABIT-ILE,
hand–arm bimanual intensive therapy including lower extremities;
M, moderate; N, no; OT, occupational therapy; PT, physical ther-
apy; S, strong; SDR, selective dorsal rhizotomy; W, weak; Y, yes.
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impossible to draw conclusions from these data. Self-care
data, however, were separately presented and demonstrated
significant gains in the areas of feeding and dressing. Two
studies with level II evidence were small RCTs on repeti-
tive transcranial magnetic stimulation80 and HABIT-ILE67
and met the AACPDM criteria for moderate and strong
methodological quality respectively. The effect of HABIT-
ILE training was significant (small to moderate effect sizes)
for manual ability, fine motor control, and self-care. Repet-
itive transcranial magnetic stimulation showed large effect
sizes (with wide confidence intervals) on passive range of
motion for the group with 5Hz stimulation immediately
after 5 days of treatment. Although there was a trend
towards improvement in muscle tone (Ashworth scores) in
the 5Hz treatment group, the results did not reach statisti-
cal significance.
DISCUSSION
To our knowledge, this review is the first to summarize
the evidence from both observational and controlled stud-
ies on the efficacy of interventions on upper limb func-
tion in bilateral CP across all domains of the ICF.
Fifteen studies were identified, but the large variety in
the content of interventions and the heterogeneity of out-
come measures prevented a meaningful synthesis of
results across studies. Most of the studies in this review
showed level IV evidence. Three small RCTs showed
level II evidence. These RCTs reported that HABIT-ILE
is effective for improving manual ability, fine motor con-
trol, and self-care; that repetitive transcranial magnetic
stimulation is modestly effective for improving passive
ROM; and that ITB and physical therapy is effective for
improving upper limb coordination and arm and fine
hand use. However, only one of these three RCTs met
the AACPDM criteria for strong methodological qual-
ity14: a study about HABIT-ILE.
HABIT-ILE is given in a day camp setting providing
6.5 hours per day intensive, task-specific training. For uni-
lateral spastic CP, there is modest evidence that intensive
activity-based, goal-directed interventions are more effec-
tive than standard care to improve upper limb function, in
addition to strong evidence for goal-directed occupational
therapy home programmes.9 The results of this review
suggest that intensive activity-based training programmes
such as HABIT-ILE could also be beneficial for children
with bilateral CP. This conclusion should, however, be
interpreted with caution, given that only one small RCT
has been conducted in which the training included both
the upper and lower limbs.
Methodological considerations, and strengths and
limitations of this review
First, the low level of evidence and weak to moderate
methodological quality of the included studies is a serious
concern. Apart from the heterogeneity in outcome mea-
sures and poor definition of the patient population, the
small sample sizes and weak to moderate methodological
quality impeded synthesis of the results. Hence, larger
(multicentre) trials are needed that use high-quality meth-
ods and well-defined outcome measures and patient popu-
lations.
Second, most interventions comprised more than one
component (with or without occupational therapy and/or
physical therapy); therefore the efficacy of an individual
component could not be established.
Third, identification of studies and comparison of results
was hampered by the use of different classification systems.
The classification as proposed by the Surveillance of Cere-
bral Palsy in Europe2 is now frequently used and has
become the criterion standard for uniform classification of
CP.
The studies reported in this review included heteroge-
neous patient groups with bilateral CP: children with
diplegia, quadriplegia, and mixed populations. In addition,
in most studies, important information about comorbidities
and the motor type of CP (GMFCS and/or MACS level)
was insufficiently described or even lacking. In four stud-
ies67,72,74,79 the MACS levels were described, but the
included patients presented with a large variety in MACS
levels (levels II–V). Hence, findings were reported in rela-
tion to neither comorbidities nor MACS levels, making
inferences impossible. Studies presented a large variety of
classifications of the motor type of CP and upper and
lower extremity function. This information is needed to
compare effects across studies and to generalize findings.
Hence, for future research, we recommend the use of uni-
form classifications both for diagnosis and for gross and
fine motor functions. The MACS and the revised edition
of the Bimanual Fine Motor Function,82 as a classification
of fine motor capacity in children with CP, are both useful
for this purpose.
Outcome measures
This systematic review shows that a variety of outcomes
were assessed, such as joint mobility, movement functions,
and self-care. However, clinically important outcomes such
as palm hygiene and pain were not assessed. In children
with severe motor types of CP (e.g. MACS levels IV and
V) these outcomes may be particularly important. Further-
more, upper limb function was evaluated by a variety of
measures that could not be categorized as upper limb
assessments nor considered to be validated for CP. For
unilateral spastic CP, several systematic reviews have sum-
marized outcome measures to evaluate upper limb func-
tion.83,84 For bilateral spastic CP, Elvrum et al.85 identified
five hand function measures and found the strongest evi-
dence of validity and reliability for the ABILHAND-Kids
and Melbourne-2. However, evidence for their responsive-
ness is still lacking. The Both Hands Assessment,86 mea-
suring the effectiveness of bimanual performance and the
extent of asymmetric hand use in children in MACS levels
I to III, has recently been developed and shown good evi-
dence of internal scale validity and item and person relia-
bility. Further high-quality studies on these and other
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measures may help to identify measurement instruments
covering all domains of the ICF, specifically for children
with bilateral CP, and facilitate the evaluation of the effi-
cacy of interventions.
Research implications
Implementing evidence from systematic reviews may be
challenging in heterogeneous populations of children with
complex disorders such as CP. Systematic reviews tend to
favour studies where randomization is easier to achieve and
which include more homogeneous populations, not always
reflecting the population seen in clinical practice. Smaller
studies using single-case designs may constitute a bridge
between research and clinical practice by taking into
account the individual variability of responses to an inter-
vention.87
CONCLUSIONS
Effective use of the upper limb in children with bilateral CP
is essential for their independence in daily life activities.11
Many treatment options are available, but these have pre-
dominantly been investigated in children with unilateral
spastic CP. Only a limited number of studies investigated
the efficacy of a variety of interventions on upper limb func-
tion in children with bilateral CP. From the studies reported
in this review, it is difficult to draw firm conclusions about
the effectiveness of these interventions. Therefore, there is
scarce evidence available to be used in clinical practice.
Nevertheless, this review is an important starting point
to understand the state of the evidence and to identify
future directions for upper limb interventions in children
with bilateral CP where possible. The study by Bleyen-
heuft et al.67 on the effects of HABIT-ILE provides level
II evidence, strong methodological quality, and shows
promising results, even though their intervention was not
entirely focused on upper limb function but integrated
with a lower limb intervention. In addition, the interven-
tion was not tailored to children with more severe motor
types of CP (MACS levels IV and V). Whether children
with these complex types can participate in a bimanual
intensive training programme, such as the HABIT-ILE
training, could be further explored using a single-case
design.
In conclusion, we recommend further research specifically
aimed at bimanual intensive, goal-directed, and task-specific
training programmes for the upper limb in children with
bilateral CP using either high-quality (multicentre) RCTs or
well-designed single-case trials.
ACKNOWLEDGEMENTS
We thank On Ying Chan from the library of medical sciences,
Radboud University Medical Centre, for assistance with the litera-
ture search, and Brenda Groen for assistance. The authors state
that they had no interests that could be perceived as posing a con-
flict or bias.
SUPPORTING INFORMATION
The following additional material may be found online:
Appendix S1: Search strategy.
Table SI: Conduct questions with item criteria for quality
assessment
Table SII: Summary of studies: interventions and participants
Table SIII: Summary of studies: outcomes, measures, and
results
Figure S1: Processes performed to identify studies for
inclusion.
REFERENCES
1. Himmelmann K, Beckung E, Hagberg G, Uvebrant P.
Gross and fine motor function and accompanying
impairments in cerebral palsy. Dev Med Child Neurol
2006; 48: 417–23.
2. Johnson A. Prevalence and characteristics of children
with cerebral palsy in Europe. Dev Med Child Neurol
2002; 44: 633–40.
3. Himmelmann K, Beckung E, Hagberg G, Uvebrant P.
Bilateral spastic cerebral palsy–prevalence through four
decades, motor function and growth. Eur J Paediatr
Neurol 2007; 11: 215–22.
4. Cans C, Dolk H, Platt MJ, et al. Recommendations
from the SCPE collaborative group for defining and
classifying cerebral palsy. Dev Med Child Neurol Suppl
2007; 109: 35–8.
5. Arner M, Eliasson AC, Nicklasson S, Sommerstein K,
H€agglund G. Hand function in cerebral palsy. Report of
367 children in a population-based longitudinal health
care program. J Hand Surg Am 2008; 33: 1337–47.
6. Eliasson AC, Krumlinde-Sundholm L, R€osblad B, et al.
The Manual Ability Classification System (MACS) for
children with cerebral palsy: scale development and
evidence of validity and reliability. Dev Med Child Neurol
2006; 48: 549–54.
7. Klevberg GL, Østensjø S, Krumlinde-Sundholm L,
Elkjær S, Jahnsen RB. Hand function in a population-
based sample of young children with unilateral or
bilateral cerebral palsy. Phys Occup Ther Pediatr 2017;
37: 528–40.
8. Shierk A, Lake A, Haas T. Review of therapeutic inter-
ventions for the upper limb classified by manual ability
in children with cerebral palsy. Semin Plast Surg 2016;
30: 14–23.
9. Sakzewski L, Ziviani J, Boyd RN. Efficacy of upper limb
therapies for unilateral cerebral palsy: a meta-analysis.
Pediatrics 2014; 133: e175–204.
10. Novak I, McIntyre S, Morgan C, et al. A systematic
review of interventions for children with cerebral palsy:
state of the evidence. Dev Med Child Neurol 2013; 55:
885–910.
11. Boyd RN, Hays RM. Current evidence for the use of
botulinum toxin type A in the management of children
with cerebral palsy: a systematic review. Eur J Neurol
2001; 8 (Suppl. 5): 1–20.
12. Dong VA, Tung IH, Siu HW, Fong KN. Studies com-
paring the efficacy of constraint-induced movement
therapy and bimanual training in children with unilateral
cerebral palsy: a systematic review. Dev Neurorehabil
2013; 16: 133–43.
13. Hoare BJ, Wallen MA, Imms C, Villanueva E, Rawicki
HB, Carey L. Botulinum toxin A as an adjunct to treat-
ment in the management of the upper limb in children
with spastic cerebral palsy (UPDATE). Cochrane Data-
base Syst Rev 2010; (1): CD003469.
14. Darrah J, Hickman R, O’Donnell M, Vogtle L, Wiart
L. AACPDM Methodology for Developing Systematic
Reviews Of Treatment Interventions (Revision 1.2). Mil-
waukee, WI: American Academy for Cerebral Palsy and
Developmental Medicine, 2008.
15. World Health Organization. International Classifica-
tion of Functioning, Disability and Health (ICF).
Geneva, Switzerland: World Health Organization,
2001.
16. Sackett DL. Evidence-Based Medicine: How to Practice
and Teach EBM. 2nd edn. New York, NY: Churchill
Livingstone, 2000.
Review 905
17. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA
statement for reporting systematic reviews and meta-
analyses of studies that evaluate health care interven-
tions: explanation and elaboration. J Clin Epidemiol
2009; 62: e1–34.
18. Ardon MS, Selles RW, Hovius SER, et al. Stronger
relation between impairment and manual capacity in the
non-dominant hand than the dominant hand in congeni-
tal hand differences; implications for surgical and thera-
peutic interventions. J Hand Ther 2014; 27: 201–8.
19. Chen CY, Mrowzinski S, Heathcock J. Movement train-
ing positively influences the motor function of upper
extremities in infants with neonatal stroke. Dev Med
Child Neurol 2014; 56(Suppl. 2): 59.
20. Hurvitz EA, Conti GE, Brown SH. Changes in move-
ment characteristics of the spastic upper extremity after
botulinum toxin injection. Arch Phys Med Rehabil 2003;
84: 444–54.
21. Kanellopoulos AD, Mavrogenis AF, Mitsiokapa EA,
et al. Long lasting benefits following the combination of
static night upper extremity splinting with botulinum
toxin A injections in cerebral palsy children. Eur J Phys
Rehabil Med 2009; 45: 501–6.
22. Kim JP, Chang WS, Cho SR, Chang JW. The effect
of bilateral globus pallidus internus deep brain stimu-
lation plus ventralis oralis thalamotomy on patients
with cerebral palsy. Stereotact Funct Neurosurg 2012;
90: 292–9.
23. Peacock WJ, Arens LJ, Berman B. Cerebral palsy spas-
ticity. Selective posterior rhizotomy. Pediatr Neurosci
1987; 13: 61–6.
24. Pitroda N, Sethi J. The effect of play therapy over con-
ventional therapy in improving the hand function of
spastic diplegic cerebral palsy children. Indian J Physio-
ther Occup Ther 2008; 2: 8–15.
25. Wallen M, O’Flaherty SJ, Waugh MC. Functional out-
comes of intramuscular botulinum toxin type a and
occupational therapy in the upper limbs of children with
cerebral palsy: a randomized controlled trial. Arch Phys
Med Rehabil 2007; 88: 1–10.
26. Meythaler JM, Guin-Renfroe S, Law C, Grabb P, Had-
ley MN. Continuously infused intrathecal baclofen over
12 months for spastic hypertonia in adolescents and
adults with cerebral palsy. Arch Phys Med Rehabil 2001;
82: 155–61.
27. Pozin I, Bdolah-Abram T, Ben-Pazi H. Levodopa does
not improve function in individuals with dystonic cere-
bral palsy. J Child Neurol 2014; 29: 534–7.
28. Puligopu AK, Purohit AK. Outcome of selective motor
fasciculotomy in the treatment of upper limb spasticity.
J Pediatr Neurosci 2011; 6 (Suppl. 1): S118–25.
29. Sokal P, Rudas M, Harat M, Szylberg Ł, Zielinski P.
Deep anterior cerebellar stimulation reduces symptoms
of secondary dystonia in patients with cerebral palsy
treated due to spasticity. Clin Neurol Neurosurg 2015;
135: 62–8.
30. Auld ML, Johnston LM. “Strong and steady”: a commu-
nity-based strength and balance exercise group for chil-
dren with cerebral palsy. Disabil Rehabil 2014; 36: 2065–
71.
31. Auvichayapat P, Aree-Uea B, Auvichayapat N, et al.
Transient changes in brain metabolites after transcranial
direct current stimulation in spastic cerebral palsy: a
pilot study. Front Neurol 2017; 8: 366.
32. Buccino G, Arisi D, Gough P, et al. Improving upper
limb motor functions through action observation treat-
ment: a pilot study in children with cerebral palsy. Dev
Med Child Neurol 2012; 54: 822–8.
33. Chu ML, Sala DA. The use of tiagabine in pediatric
spasticity management. Dev Med Child Neurol 2006; 48:
456–9.
34. Crompton J, Imms C, McCoy AT, et al. Group-based
task-related training for children with cerebral palsy: a
pilot study. Phys Occup Ther Pediatr 2007; 27: 43–65.
35. Elliott C, Reid S, Hamer P, Alderson J, Elliott B. Lycra
() arm splints improve movement fluency in children
with cerebral palsy. Gait Posture 2011; 33: 214–9.
36. Gugger Y, Kalb KH, Prommersberger KJ, van Schoon-
hoven J. Brachioradialis rerouting for restoration of
forearm supination or pronation [article in German].
Oper Orthop Traumatol 2013; 25: 350–9.
37. Ho JJ, Wang TM, Shieh JY, Wu KW, Huang SC, Kuo
KN. Pronator teres transfer for forearm and wrist defor-
mity in cerebral palsy children. J Pediatr Orthop 2015;
35: 412–8.
38. Howcroft J, Klejman S, Fehlings D, et al. Active video
game play in children with cerebral palsy: potential for
physical activity promotion and rehabilitation therapies.
Arch Phys Med Rehabil 2012; 93: 1448–56.
39. Jesinkey K, Naslund A, Hirschfeld H. Initiation of
reaching when standing with and without DAFOs in
children with spastic diplegia. Adv Physiother 2005; 7:
144–53.
40. Johansson AM, Domell€of E, R€onnqvist L. Timing train-
ing in three children with diplegic cerebral palsy: short-
and long-term effects on upper-limb movement organi-
zation and functioning. Front Neurol 2014; 5: 38.
41. Ju YH, You JY, Cherng RJ. Effect of task constraint on
reaching performance in children with spastic diplegic
cerebral palsy. Res Dev Disabil 2010; 31: 1076–82.
42. Kluzik J, Fetters L, Coryell J. Quantification of control:
a preliminary study of effects of neurodevelopmental
treatment on reaching in children with spastic cerebral
palsy. Phys Ther 1990; 70: 65–76.
43. Lee JA, You JH, Kim DA, et al. Effects of functional
movement strength training on strength, muscle size,
kinematics, and motor function in cerebral palsy: a
3-month follow-up. NeuroRehabilitation 2013; 32: 287–95.
44. Morota N, Kameyama S, Masuda M, et al. Functional
posterior rhizotomy for severely disabled children with
mixed type cerebral palsy. Acta Neurochir Suppl 2003; 87:
99–102.
45. Murphy AM, Milo-Manson G, Best A, Campbell KA,
Fehlings D. Impact of modafinil on spasticity reduction
and quality of life in children with CP. Dev Med Child
Neurol 2008; 50: 510–4.
46. N€aslund A, Sundelin G, Hirschfeld H. Reach perfor-
mance and postural adjustments during standing in chil-
dren with severe spastic diplegia using dynamic ankle-foot
orthoses. J Rehabil Med 2007; 39: 715–23.
47. Ojemann JG, McKinstry RC, Mukherjee P, Park TS,
Burton H. Hand somatosensory cortex activity following
selective dorsal rhizotomy: report of three cases with
fMRI. Childs Nerv Syst 2005; 21: 115–21.
48. Schneiberg S, McKinley PA, Sveistrup H, Gisel E, Mayo
NE, Levin MF. The effectiveness of task-oriented inter-
vention and trunk restraint on upper limb movement
quality in children with cerebral palsy. Dev Med Child
Neurol 2010; 52: e245–53.
49. Unnithan VB, Katsimanis G, Evangelinou C, Kosmas C,
Kandrali I, Kellis E. Effect of strength and aerobic train-
ing in children with cerebral palsy. Med Sci Sports Exerc
2007; 39: 1902–9.
50. Beach WR, Strecker WB, Coe J, Manske PR, Schoe-
necker PL, Dailey L. Use of the Green transfer in treat-
ment of patients with spastic cerebral palsy: 17-year
experience. J Pediatr Orthop 1991; 11: 731–6.
51. Cahuzac M, Cahuzac JP, Claverie P. Functional results
and indications for surgery in the child with a motor
deficit of cerebral origin. Chirurgie 1976; 102: 798–803
[in French].
52. Domzalski M, Inan M, Littleton AG, Miller F. Pec-
toralis major release to improve shoulder abduction in
children with cerebral palsy. J Pediatr Orthop 2007; 27:
457–61.
53. Schijman E, Erro MG, Meana NV. Selective posterior
rhizotomy: experience of 30 cases. Childs Nerv Syst 1993;
9: 474–7.
54. Chen CL, Wu CY, Chen HC, et al. Application of a
novel integrated pointing device apparatus for children
with cerebral palsy. Chang Gung Med J 2006; 29: 380–7.
55. Copeland L, Edwards P, Thorley M, et al. Safety of
botulinum toxin type A in a double blind SHAM con-
trolled trial of children with marked bilateral cerebral
palsy to improve care and comfort goals. Dev Med Child
Neurol 2011; 53 (Suppl. 5): 3–4.
56. Ju YH, Hwang IS, Cherng RJ. Postural adjustment of
children with spastic diplegic cerebral palsy during
seated hand reaching in different directions. Arch Phys
Med Rehabil 2012; 93: 471–9.
57. Taussig G, Pilliard D. Triceps lengthening in children
with cerebral palsy performed before the age of six
years. Results at the end of growth. Rev Chir Orthop
Reparatrice Appar Mot 1988; 74: 79–84 [in French].
58. Papavasiliou AS, Nikaina I, Bouros P, Rizou I, Fil-
iopoulos C. Botulinum toxin treatment in upper limb
spasticity: treatment consistency. Eur J Paediatr Neurol
2012; 16: 237–42.
59. Park EY, Kim WH. Effect of neurodevelopmental treat-
ment-based physical therapy on the change of muscle
strength, spasticity, and gross motor function in children
with spastic cerebral palsy. J Phys Ther Sci 2017; 29:
966–9.
60. Purohit AK, Reddy SS, Puligopu AK. Results of selec-
tive motor fasciculotomy in spastic upper limbs due to
cerebral palsy. Dev Med Child Neurol 2013; 55 (Suppl.
3): 10–1.
61. Unger M, Faure M, Frieg A. Strength training in ado-
lescent learners with cerebral palsy: a randomized con-
trolled trial. Clin Rehabil 2006; 20: 469–77.
62. Boyd RN, Edwards P, Thorley M, et al. Double-blind
randomized trial of intramuscular botulinum toxin type
A and therapy compared to SHAM and therapy for
care and comfort goals in children with marked bilat-
eral cerebral palsy. Dev Med Child Neurol 2011; 53
(Suppl. 5): 3.
906 Developmental Medicine & Child Neurology 2019, 61: 899–907
63. Friedman A, Diamond M, Johnston MV, Daffner C.
Effects of botulinum toxin A on upper limb spasticity in
children with cerebral palsy. Am J Phys Med Rehabil
2000; 79: 53–9.
64. Gooch JL, Oberg WA, Grams B, Ward LA, Walker
ML. Care provider assessment of intrathecal baclofen in
children. Dev Med Child Neurol 2004; 46: 548–52.
65. Sorsdahl AB, Moe-Nilssen R, Kaale HK, Rieber J,
Strand LI. Change in basic motor abilities, quality of
movement and everyday activities following intensive,
goal-directed, activity-focused physiotherapy in a group
setting for children with cerebral palsy. BMC Pediatr
2010; 10: 26.
66. AlSaif AA, Alsenany S. Effects of interactive games on
motor performance in children with spastic cerebral
palsy. J Phys Ther Sci 2015; 27: 2001–3.
67. Bleyenheuft Y, Ebner-Karestinos D, Surana B, et al.
Intensive upper- and lower-extremity training for chil-
dren with bilateral cerebral palsy: a quasi-randomized
trial. Dev Med Child Neurol 2017; 59: 625–33.
68. Buckon CE, Sienko Thomas S, Aiona MD, Piatt JH.
Assessment of upper-extremity function in children with
spastic diplegia before and after selective dorsal rhizo-
tomy. Dev Med Child Neurol 1996; 38: 967–75.
69. Buckon CE, Thomas SS, Harris GE, Piatt JH Jr, Aiona
MD, Sussman MD. Objective measurement of muscle
strength in children with spastic diplegia after selective
dorsal rhizotomy. Arch Phys Med Rehabil 2002; 83: 454–60.
70. Campbell WM, Ferrel A, McLaughlin JF, et al. Long-
term safety and efficacy of continuous intrathecal baclo-
fen. Dev Med Child Neurol 2002; 44: 660–5.
71. Dudgeon BJ, Libby AK, McLaughlin JF, Hays RM,
Bjornson KF, Roberts TS. Prospective measurement of
functional changes after selective dorsal rhizotomy. Arch
Phys Med Rehabil 1994; 75: 46–53.
72. Lee JS, Lee KB, Lee YR, et al. Botulinum toxin treat-
ment on upper limb function in school age children with
bilateral spastic cerebral palsy: one year follow-up. Ann
Rehabil Med 2013; 37: 328–35.
73. Lewin JE, Mix CM, Gaebler-Spira D. Self-help and
upper extremity changes in 36 children with cerebral
palsy subsequent to selective posterior rhizotomy and
intensive occupational and physical therapy. Phys Occup
Ther Pediatr 1994; 13: 25–42.
74. Lin YC, Huang CY, Lin IL, Shieh JY, Chung YT,
Chen KL. Evaluating functional outcomes of botuli-
num toxin type A injection combined with occupa-
tional therapy in the upper limbs of children with
cerebral palsy: a 9-month follow-up from the perspec-
tives of both child and caregiver. PLoS One 2015; 10:
e0142769.
75. Montgomery D, Goldberg J, Amar M, et al. Effects of
hyperbaric oxygen therapy on children with spastic
diplegic cerebral palsy: a pilot project. Undersea Hyperb
Med 1999; 26: 235–42.
76. Noronha J, Bundy A, Groll J. The effect of positioning
on the hand function of boys with cerebral palsy. Am J
Occup Ther 1989; 43: 507–12.
77. Shin JW, Song GB, Hwangbo G. Effects of conven-
tional neurological treatment and a virtual reality
training program on eye-hand coordination in chil-
dren with cerebral palsy. J Phys Ther Sci 2015; 27:
2151–4.
78. Shurtleff TL, Standeven JW, Engsberg JR. Changes in
dynamic trunk/head stability and functional reach after
hippotherapy. Arch Phys Med Rehabil 2009; 90: 1185–95.
79. Turconi AC, Biffi E, Maghini C, Peri E, Servodio Iam-
marone F, Gagliardi C. Can new technologies improve
upper limb performance in grown-up diplegic children?
Eur J Phys Rehabil Med 2016; 52: 672–81.
80. Valle AC, Dionisio K, Pitskel NB, et al. Low and high
frequency repetitive transcranial magnetic stimulation
for the treatment of spasticity. Dev Med Child Neurol
2007; 49: 534–8.
81. Palisano R, Rosenbaum P, Walter S, Russell D, Wood
E, Galuppi B. Development and reliability of a system
to classify gross motor function in children with cerebral
palsy. Dev Med Child Neurol 1997; 39: 214–23.
82. Elvrum AG, Beckung E, Saether R, Lydersen S, Vik
T, Himmelmann K. Bimanual capacity of children
with cerebral palsy: intra- and interrater reliability of a
revised edition of the Bimanual Fine Motor Function
Classification. Phys Occup Ther Pediatr 2017; 37: 239–
51.
83. Lemmens RJ, Timmermans AA, Janssen-Potten YJ,
Smeets RJ, Seelen HA. Valid and reliable instruments
for arm-hand assessment at ICF activity level in persons
with hemiplegia: a systematic review. BMC Neurol 2012;
12: 21.
84. Gilmore R, Sakzewski L, Boyd R. Upper limb activity
measures for 5- to 16-year-old children with congenital
hemiplegia: a systematic review. Dev Med Child Neurol
2010; 52: 14–21.
85. Elvrum AK, Saether R, Riphagen II, Vik T. Outcome
measures evaluating hand function in children with
bilateral cerebral palsy: a systematic review. Dev Med
Child Neurol 2016; 58: 662–71.
86. Elvrum AG, Zethræus BM, Vik T, Krumlinde-Sund-
holm L. Development and validation of the Both Hands
Assessment for children with bilateral cerebral palsy.
Phys Occup Ther Pediatr 2018; 38: 113–26.
87. Romeiser-Logan L, Slaughter R, Hickman R. Single-
subject research designs in pediatric rehabilitation: a
valuable step towards knowledge translation. Dev Med
Child Neurol 2017; 59: 574–80.
Review 907
RESUMEN
INTERVENCIONES PARA MEJORAR LA FUNCION DE LAS EXTREMIDADES SUPERIORES EN NI~NOS CON PARALISIS CEREBRAL
BILATERAL: UNA REVISION SISTEMATICA
OBJETIVO Revisar sistematicamente la eficacia de la funcion de la extremidad superior con las intervenciones realizadas en ni~nos
de 0 a 19 a~nos de edad con paralisis cerebral bilateral basada en medidas de la funcion de la extremidad superior, de actividades
y / o participacion, segun la Clasificacion Internacional del Funcionamiento, de la Discapacidad y de la Salud.
METODO Se investigaron desde su inicio hasta septiembre del 2017 las siguientes bases de datos: Cochrane, PubMed, Embase,
CINAHL y Web of Science. Tres evaluadores independientes analizaron la calidad metodologica y la calidad de la evidencia
utilizando el nivel de evidencia de Sackett y las guias de la Academia Americana para la Paralisis Cerebral y Medicina del
Desarrollo (AACPDM).
RESULTADOS Quince estudios con una gran variedad de intervenciones y heterogeneidad en las escalas de resultado cumplieron
con los criterios de inclusion. Doce estudios proporcionaron evidencia nivel IV de acuerdo con las guıas de la AACPDM. Otros tres
ensayos peque~nos controlados y aleatorios se clasificaron como nivel II de evidencia. Solo uno de estos ensayos mostro una
calidad metodologica solida que consista en un estudio sobre terapia bimanual intensiva mano-brazo que incluıa extremidades
inferiores.
INTERPRETACION Se identificaron una gran variedad de intervenciones, heterogeneidad en las escalas de medicion de los
resultados, y en general una calidad metodologica de debil a moderada para la mayorıa de los estudios. Recomendamos
investigaciones adicionales dirigidas especıficamente a programas de entrenamiento bimanual, orientado a objetivos especıficos
para la tarea del miembro superior en ni~nos con paralisis cerebral bilateral, utilizando ensayos de alta calidad (multicentricos) o
ensayos dirigidos a estudiar solo un concepto bien dise~nados.
RESUMO
INTERVENC ~OES PARA MELHORAR A FUNC ~AO DO MEMBRO SUPERIOR EM CRIANCAS COM PARALISIA CEREBRAL BILATERAL:
UMA REVIS~AO SISTEMATICA
OBJETIVO Revisar sistematicamente a eficacia de intervenc~oes para a func~ao do membro superior em criancas de 0 a 19 anos de
idade com paralisia cerebral bilateral com base em medidas de resultado da func~ao do membro superior e medidas de atividades
e/ou participac~ao de acordo com a Classificac~ao Internacional de Funcionalidade, Incapacidade e Saude.
METODO Cochrane, PubMed, Embase, CINAHL, e Web of Science foram pesquisadas do inıcio ate setembro de 2017. A qualidade
metodologica e forca da evide^ncia foram analisados por tre^s avaliadores independentes usando o nıvel Sackett’s e evide^ncia e as
diretrizes da Academia Americana de Paralisia Cerebral e Medicina do Desenvolviemnto (AACPDM).
RESULTADOS Quinze estudos com uma grande variedade de intervenc~oes e heterogeneidade de medidas de resultado atenderam
aos criterios de inclus~ao. Doze estudos forneceram evide^ncia nıvel IV de acordo com as diretrizes da AACPDM. Para tre^s pequenos
estudos randomizados controlados o nıvel de evide^ncia foi II. Apenas um destes estudos mostrou forte qualidade metodologica:
um estudo sobre terapia intensive bimanual m~ao-braco incluindo as extremidades inferiores.
INTERPRETAC~AO Identificamos uma grande variedade de intervenc~oes, heterogeneidade em medidas de resultado, e em geral
qualidade metodologica de fraca a moderada para a maioria dos estudos. Recomendamos mais pesquisas especificamente
voltadas para programas de treinamento intensivos bimanuais, direcionados a objetivos e especıficos para tarefas para o membro
superior de criancas com paralisia cerebral usando ou estudos de alta qualidade (multice^ntricos) ou estudos de sujeito unico bem
desenhados.
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